Baidu
map
INVEST NEW DRUG 润色咨询

INVESTIGATIONAL NEW DRUGS

出版年份:1983 年文章数:1718 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:1.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2212854, encodeId=6cea221285452, content=偏重的研究方向:肿瘤;药物基础<br>经验分享:最近有没有投稿的小伙伴,这个杂志现在速度慢嘛,technical check一天多了都没动静,其他杂志check不就一小会么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Tue Jul 02 19:43:42 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178727, encodeId=79f721e872788, content=偏重的研究方向:肿瘤;药物<br>经验分享:reviewers invited 1 个月了没动静,找不到审稿人会退稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Tue Jan 02 09:44:27 CST 2024, time=2024-01-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2152225, encodeId=0ff52152225fc, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;药物<br>经验分享:23.5.1日投的稿<br>23.5.4 同行评审<br>23.6.12 返回意见<br>23.6.18 修回<br>23.6.21 接受<br>23.7.9 版权和APC问题<br>23.7.12 Pubmed 检索到<br><br>审稿人还是很友好专业的,个人觉得这个杂志1个月能找到审稿人还是很幸运的。接受后半个月没有任何动静,一旦给你发版权后,就很快了。可以选择没有版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ca5448733, createdName=ms1000000639469053, createdTime=Fri Aug 11 09:12:06 CST 2023, time=2023-08-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151942, encodeId=d07e215194211, content=请问案例报道可以投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=393e6422350, createdName=ms1000001764947106, createdTime=Wed Aug 09 14:05:45 CST 2023, time=2023-08-09, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=805722, encodeId=17a3805e22c1, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:六月十五投了篇,在编辑那停留了半个月后就under review,7月14日,外审结束,当晚就给了修稿,修稿意见是这样的:这是篇很不错的文章,总结一下很不错的工作,但存在多处语法的错误,需要对语言进行编辑修改,没让我补实验。收到修稿函后,花了半个月修稿完就提交了。提交后的第二天就从reviews completed 变为Accept 了。编辑挺负责的,总的来说还是挺快的…<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=832, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Sun Aug 02 10:34:35 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106157, encodeId=bf59210615e1d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:22年九月初投的稿,已经三个半月了还没外审回来,我真的无语了,看别人的都是一两个月就外审回来,再不外审回来真的生气了!!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Thu Dec 15 10:50:01 CST 2022, time=2022-12-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2106034, encodeId=15b42106034f6, content=编辑老师很认真负责,投稿接受修回都很快,让人感觉幸福来的很突然。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee172609672, createdName=yuanp25167257, createdTime=Wed Dec 14 17:00:18 CST 2022, time=2022-12-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223255, encodeId=d479122325552, content=这个杂志邮件通知手稿已经被接收了,但是接下来一周任何操作提示都没有,应该怎么办啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7965534931, createdName=lin112, createdTime=Sun May 29 23:06:38 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079947, encodeId=921810e994758, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床研究<br>经验分享:很不错的期刊,审稿速度,审稿效率都是很不错的。很欢迎上市后的临床研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/0A711D2CC5E0F3D07C1F1766E5448576/100, createdBy=6cd12546777, createdName=大鸟快跑, createdTime=Tue Dec 14 14:41:52 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092203, encodeId=b2c4109220373, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2024-07-02 ms7000000138744330 来自江苏省

    偏重的研究方向:肿瘤;药物基础
    经验分享:最近有没有投稿的小伙伴,这个杂志现在速度慢嘛,technical check一天多了都没动静,其他杂志check不就一小会么

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2212854, encodeId=6cea221285452, content=偏重的研究方向:肿瘤;药物基础<br>经验分享:最近有没有投稿的小伙伴,这个杂志现在速度慢嘛,technical check一天多了都没动静,其他杂志check不就一小会么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Tue Jul 02 19:43:42 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178727, encodeId=79f721e872788, content=偏重的研究方向:肿瘤;药物<br>经验分享:reviewers invited 1 个月了没动静,找不到审稿人会退稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Tue Jan 02 09:44:27 CST 2024, time=2024-01-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2152225, encodeId=0ff52152225fc, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;药物<br>经验分享:23.5.1日投的稿<br>23.5.4 同行评审<br>23.6.12 返回意见<br>23.6.18 修回<br>23.6.21 接受<br>23.7.9 版权和APC问题<br>23.7.12 Pubmed 检索到<br><br>审稿人还是很友好专业的,个人觉得这个杂志1个月能找到审稿人还是很幸运的。接受后半个月没有任何动静,一旦给你发版权后,就很快了。可以选择没有版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ca5448733, createdName=ms1000000639469053, createdTime=Fri Aug 11 09:12:06 CST 2023, time=2023-08-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151942, encodeId=d07e215194211, content=请问案例报道可以投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=393e6422350, createdName=ms1000001764947106, createdTime=Wed Aug 09 14:05:45 CST 2023, time=2023-08-09, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=805722, encodeId=17a3805e22c1, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:六月十五投了篇,在编辑那停留了半个月后就under review,7月14日,外审结束,当晚就给了修稿,修稿意见是这样的:这是篇很不错的文章,总结一下很不错的工作,但存在多处语法的错误,需要对语言进行编辑修改,没让我补实验。收到修稿函后,花了半个月修稿完就提交了。提交后的第二天就从reviews completed 变为Accept 了。编辑挺负责的,总的来说还是挺快的…<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=832, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Sun Aug 02 10:34:35 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106157, encodeId=bf59210615e1d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:22年九月初投的稿,已经三个半月了还没外审回来,我真的无语了,看别人的都是一两个月就外审回来,再不外审回来真的生气了!!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Thu Dec 15 10:50:01 CST 2022, time=2022-12-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2106034, encodeId=15b42106034f6, content=编辑老师很认真负责,投稿接受修回都很快,让人感觉幸福来的很突然。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee172609672, createdName=yuanp25167257, createdTime=Wed Dec 14 17:00:18 CST 2022, time=2022-12-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223255, encodeId=d479122325552, content=这个杂志邮件通知手稿已经被接收了,但是接下来一周任何操作提示都没有,应该怎么办啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7965534931, createdName=lin112, createdTime=Sun May 29 23:06:38 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079947, encodeId=921810e994758, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床研究<br>经验分享:很不错的期刊,审稿速度,审稿效率都是很不错的。很欢迎上市后的临床研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/0A711D2CC5E0F3D07C1F1766E5448576/100, createdBy=6cd12546777, createdName=大鸟快跑, createdTime=Tue Dec 14 14:41:52 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092203, encodeId=b2c4109220373, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2024-01-02 ms4000001640011867 来自福建省

    偏重的研究方向:肿瘤;药物
    经验分享:reviewers invited 1 个月了没动静,找不到审稿人会退稿吗

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2212854, encodeId=6cea221285452, content=偏重的研究方向:肿瘤;药物基础<br>经验分享:最近有没有投稿的小伙伴,这个杂志现在速度慢嘛,technical check一天多了都没动静,其他杂志check不就一小会么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Tue Jul 02 19:43:42 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178727, encodeId=79f721e872788, content=偏重的研究方向:肿瘤;药物<br>经验分享:reviewers invited 1 个月了没动静,找不到审稿人会退稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Tue Jan 02 09:44:27 CST 2024, time=2024-01-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2152225, encodeId=0ff52152225fc, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;药物<br>经验分享:23.5.1日投的稿<br>23.5.4 同行评审<br>23.6.12 返回意见<br>23.6.18 修回<br>23.6.21 接受<br>23.7.9 版权和APC问题<br>23.7.12 Pubmed 检索到<br><br>审稿人还是很友好专业的,个人觉得这个杂志1个月能找到审稿人还是很幸运的。接受后半个月没有任何动静,一旦给你发版权后,就很快了。可以选择没有版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ca5448733, createdName=ms1000000639469053, createdTime=Fri Aug 11 09:12:06 CST 2023, time=2023-08-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151942, encodeId=d07e215194211, content=请问案例报道可以投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=393e6422350, createdName=ms1000001764947106, createdTime=Wed Aug 09 14:05:45 CST 2023, time=2023-08-09, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=805722, encodeId=17a3805e22c1, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:六月十五投了篇,在编辑那停留了半个月后就under review,7月14日,外审结束,当晚就给了修稿,修稿意见是这样的:这是篇很不错的文章,总结一下很不错的工作,但存在多处语法的错误,需要对语言进行编辑修改,没让我补实验。收到修稿函后,花了半个月修稿完就提交了。提交后的第二天就从reviews completed 变为Accept 了。编辑挺负责的,总的来说还是挺快的…<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=832, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Sun Aug 02 10:34:35 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106157, encodeId=bf59210615e1d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:22年九月初投的稿,已经三个半月了还没外审回来,我真的无语了,看别人的都是一两个月就外审回来,再不外审回来真的生气了!!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Thu Dec 15 10:50:01 CST 2022, time=2022-12-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2106034, encodeId=15b42106034f6, content=编辑老师很认真负责,投稿接受修回都很快,让人感觉幸福来的很突然。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee172609672, createdName=yuanp25167257, createdTime=Wed Dec 14 17:00:18 CST 2022, time=2022-12-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223255, encodeId=d479122325552, content=这个杂志邮件通知手稿已经被接收了,但是接下来一周任何操作提示都没有,应该怎么办啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7965534931, createdName=lin112, createdTime=Sun May 29 23:06:38 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079947, encodeId=921810e994758, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床研究<br>经验分享:很不错的期刊,审稿速度,审稿效率都是很不错的。很欢迎上市后的临床研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/0A711D2CC5E0F3D07C1F1766E5448576/100, createdBy=6cd12546777, createdName=大鸟快跑, createdTime=Tue Dec 14 14:41:52 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092203, encodeId=b2c4109220373, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2023-08-11 ms1000000639469053 来自广东省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤;药物
    经验分享:23.5.1日投的稿
    23.5.4 同行评审
    23.6.12 返回意见
    23.6.18 修回
    23.6.21 接受
    23.7.9 版权和APC问题
    23.7.12 Pubmed 检索到

    审稿人还是很友好专业的,个人觉得这个杂志1个月能找到审稿人还是很幸运的。接受后半个月没有任何动静,一旦给你发版权后,就很快了。可以选择没有版面费。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2212854, encodeId=6cea221285452, content=偏重的研究方向:肿瘤;药物基础<br>经验分享:最近有没有投稿的小伙伴,这个杂志现在速度慢嘛,technical check一天多了都没动静,其他杂志check不就一小会么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Tue Jul 02 19:43:42 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178727, encodeId=79f721e872788, content=偏重的研究方向:肿瘤;药物<br>经验分享:reviewers invited 1 个月了没动静,找不到审稿人会退稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Tue Jan 02 09:44:27 CST 2024, time=2024-01-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2152225, encodeId=0ff52152225fc, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;药物<br>经验分享:23.5.1日投的稿<br>23.5.4 同行评审<br>23.6.12 返回意见<br>23.6.18 修回<br>23.6.21 接受<br>23.7.9 版权和APC问题<br>23.7.12 Pubmed 检索到<br><br>审稿人还是很友好专业的,个人觉得这个杂志1个月能找到审稿人还是很幸运的。接受后半个月没有任何动静,一旦给你发版权后,就很快了。可以选择没有版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ca5448733, createdName=ms1000000639469053, createdTime=Fri Aug 11 09:12:06 CST 2023, time=2023-08-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151942, encodeId=d07e215194211, content=请问案例报道可以投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=393e6422350, createdName=ms1000001764947106, createdTime=Wed Aug 09 14:05:45 CST 2023, time=2023-08-09, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=805722, encodeId=17a3805e22c1, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:六月十五投了篇,在编辑那停留了半个月后就under review,7月14日,外审结束,当晚就给了修稿,修稿意见是这样的:这是篇很不错的文章,总结一下很不错的工作,但存在多处语法的错误,需要对语言进行编辑修改,没让我补实验。收到修稿函后,花了半个月修稿完就提交了。提交后的第二天就从reviews completed 变为Accept 了。编辑挺负责的,总的来说还是挺快的…<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=832, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Sun Aug 02 10:34:35 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106157, encodeId=bf59210615e1d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:22年九月初投的稿,已经三个半月了还没外审回来,我真的无语了,看别人的都是一两个月就外审回来,再不外审回来真的生气了!!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Thu Dec 15 10:50:01 CST 2022, time=2022-12-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2106034, encodeId=15b42106034f6, content=编辑老师很认真负责,投稿接受修回都很快,让人感觉幸福来的很突然。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee172609672, createdName=yuanp25167257, createdTime=Wed Dec 14 17:00:18 CST 2022, time=2022-12-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223255, encodeId=d479122325552, content=这个杂志邮件通知手稿已经被接收了,但是接下来一周任何操作提示都没有,应该怎么办啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7965534931, createdName=lin112, createdTime=Sun May 29 23:06:38 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079947, encodeId=921810e994758, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床研究<br>经验分享:很不错的期刊,审稿速度,审稿效率都是很不错的。很欢迎上市后的临床研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/0A711D2CC5E0F3D07C1F1766E5448576/100, createdBy=6cd12546777, createdName=大鸟快跑, createdTime=Tue Dec 14 14:41:52 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092203, encodeId=b2c4109220373, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2023-08-09 ms1000001764947106 来自内蒙古

    请问案例报道可以投吗?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2212854, encodeId=6cea221285452, content=偏重的研究方向:肿瘤;药物基础<br>经验分享:最近有没有投稿的小伙伴,这个杂志现在速度慢嘛,technical check一天多了都没动静,其他杂志check不就一小会么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Tue Jul 02 19:43:42 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178727, encodeId=79f721e872788, content=偏重的研究方向:肿瘤;药物<br>经验分享:reviewers invited 1 个月了没动静,找不到审稿人会退稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Tue Jan 02 09:44:27 CST 2024, time=2024-01-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2152225, encodeId=0ff52152225fc, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;药物<br>经验分享:23.5.1日投的稿<br>23.5.4 同行评审<br>23.6.12 返回意见<br>23.6.18 修回<br>23.6.21 接受<br>23.7.9 版权和APC问题<br>23.7.12 Pubmed 检索到<br><br>审稿人还是很友好专业的,个人觉得这个杂志1个月能找到审稿人还是很幸运的。接受后半个月没有任何动静,一旦给你发版权后,就很快了。可以选择没有版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ca5448733, createdName=ms1000000639469053, createdTime=Fri Aug 11 09:12:06 CST 2023, time=2023-08-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151942, encodeId=d07e215194211, content=请问案例报道可以投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=393e6422350, createdName=ms1000001764947106, createdTime=Wed Aug 09 14:05:45 CST 2023, time=2023-08-09, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=805722, encodeId=17a3805e22c1, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:六月十五投了篇,在编辑那停留了半个月后就under review,7月14日,外审结束,当晚就给了修稿,修稿意见是这样的:这是篇很不错的文章,总结一下很不错的工作,但存在多处语法的错误,需要对语言进行编辑修改,没让我补实验。收到修稿函后,花了半个月修稿完就提交了。提交后的第二天就从reviews completed 变为Accept 了。编辑挺负责的,总的来说还是挺快的…<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=832, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Sun Aug 02 10:34:35 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106157, encodeId=bf59210615e1d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:22年九月初投的稿,已经三个半月了还没外审回来,我真的无语了,看别人的都是一两个月就外审回来,再不外审回来真的生气了!!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Thu Dec 15 10:50:01 CST 2022, time=2022-12-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2106034, encodeId=15b42106034f6, content=编辑老师很认真负责,投稿接受修回都很快,让人感觉幸福来的很突然。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee172609672, createdName=yuanp25167257, createdTime=Wed Dec 14 17:00:18 CST 2022, time=2022-12-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223255, encodeId=d479122325552, content=这个杂志邮件通知手稿已经被接收了,但是接下来一周任何操作提示都没有,应该怎么办啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7965534931, createdName=lin112, createdTime=Sun May 29 23:06:38 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079947, encodeId=921810e994758, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床研究<br>经验分享:很不错的期刊,审稿速度,审稿效率都是很不错的。很欢迎上市后的临床研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/0A711D2CC5E0F3D07C1F1766E5448576/100, createdBy=6cd12546777, createdName=大鸟快跑, createdTime=Tue Dec 14 14:41:52 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092203, encodeId=b2c4109220373, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2020-08-02 1424056585

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享:六月十五投了篇,在编辑那停留了半个月后就under review,7月14日,外审结束,当晚就给了修稿,修稿意见是这样的:这是篇很不错的文章,总结一下很不错的工作,但存在多处语法的错误,需要对语言进行编辑修改,没让我补实验。收到修稿函后,花了半个月修稿完就提交了。提交后的第二天就从reviews completed 变为Accept 了。编辑挺负责的,总的来说还是挺快的…#肿瘤#

    9

    展开9条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2212854, encodeId=6cea221285452, content=偏重的研究方向:肿瘤;药物基础<br>经验分享:最近有没有投稿的小伙伴,这个杂志现在速度慢嘛,technical check一天多了都没动静,其他杂志check不就一小会么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Tue Jul 02 19:43:42 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178727, encodeId=79f721e872788, content=偏重的研究方向:肿瘤;药物<br>经验分享:reviewers invited 1 个月了没动静,找不到审稿人会退稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Tue Jan 02 09:44:27 CST 2024, time=2024-01-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2152225, encodeId=0ff52152225fc, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;药物<br>经验分享:23.5.1日投的稿<br>23.5.4 同行评审<br>23.6.12 返回意见<br>23.6.18 修回<br>23.6.21 接受<br>23.7.9 版权和APC问题<br>23.7.12 Pubmed 检索到<br><br>审稿人还是很友好专业的,个人觉得这个杂志1个月能找到审稿人还是很幸运的。接受后半个月没有任何动静,一旦给你发版权后,就很快了。可以选择没有版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ca5448733, createdName=ms1000000639469053, createdTime=Fri Aug 11 09:12:06 CST 2023, time=2023-08-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151942, encodeId=d07e215194211, content=请问案例报道可以投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=393e6422350, createdName=ms1000001764947106, createdTime=Wed Aug 09 14:05:45 CST 2023, time=2023-08-09, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=805722, encodeId=17a3805e22c1, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:六月十五投了篇,在编辑那停留了半个月后就under review,7月14日,外审结束,当晚就给了修稿,修稿意见是这样的:这是篇很不错的文章,总结一下很不错的工作,但存在多处语法的错误,需要对语言进行编辑修改,没让我补实验。收到修稿函后,花了半个月修稿完就提交了。提交后的第二天就从reviews completed 变为Accept 了。编辑挺负责的,总的来说还是挺快的…<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=832, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Sun Aug 02 10:34:35 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106157, encodeId=bf59210615e1d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:22年九月初投的稿,已经三个半月了还没外审回来,我真的无语了,看别人的都是一两个月就外审回来,再不外审回来真的生气了!!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Thu Dec 15 10:50:01 CST 2022, time=2022-12-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2106034, encodeId=15b42106034f6, content=编辑老师很认真负责,投稿接受修回都很快,让人感觉幸福来的很突然。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee172609672, createdName=yuanp25167257, createdTime=Wed Dec 14 17:00:18 CST 2022, time=2022-12-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223255, encodeId=d479122325552, content=这个杂志邮件通知手稿已经被接收了,但是接下来一周任何操作提示都没有,应该怎么办啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7965534931, createdName=lin112, createdTime=Sun May 29 23:06:38 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079947, encodeId=921810e994758, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床研究<br>经验分享:很不错的期刊,审稿速度,审稿效率都是很不错的。很欢迎上市后的临床研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/0A711D2CC5E0F3D07C1F1766E5448576/100, createdBy=6cd12546777, createdName=大鸟快跑, createdTime=Tue Dec 14 14:41:52 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092203, encodeId=b2c4109220373, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-12-15 ms5000002035322087 来自重庆

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤
    经验分享:22年九月初投的稿,已经三个半月了还没外审回来,我真的无语了,看别人的都是一两个月就外审回来,再不外审回来真的生气了!!!!!!

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2212854, encodeId=6cea221285452, content=偏重的研究方向:肿瘤;药物基础<br>经验分享:最近有没有投稿的小伙伴,这个杂志现在速度慢嘛,technical check一天多了都没动静,其他杂志check不就一小会么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Tue Jul 02 19:43:42 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178727, encodeId=79f721e872788, content=偏重的研究方向:肿瘤;药物<br>经验分享:reviewers invited 1 个月了没动静,找不到审稿人会退稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Tue Jan 02 09:44:27 CST 2024, time=2024-01-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2152225, encodeId=0ff52152225fc, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;药物<br>经验分享:23.5.1日投的稿<br>23.5.4 同行评审<br>23.6.12 返回意见<br>23.6.18 修回<br>23.6.21 接受<br>23.7.9 版权和APC问题<br>23.7.12 Pubmed 检索到<br><br>审稿人还是很友好专业的,个人觉得这个杂志1个月能找到审稿人还是很幸运的。接受后半个月没有任何动静,一旦给你发版权后,就很快了。可以选择没有版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ca5448733, createdName=ms1000000639469053, createdTime=Fri Aug 11 09:12:06 CST 2023, time=2023-08-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151942, encodeId=d07e215194211, content=请问案例报道可以投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=393e6422350, createdName=ms1000001764947106, createdTime=Wed Aug 09 14:05:45 CST 2023, time=2023-08-09, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=805722, encodeId=17a3805e22c1, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:六月十五投了篇,在编辑那停留了半个月后就under review,7月14日,外审结束,当晚就给了修稿,修稿意见是这样的:这是篇很不错的文章,总结一下很不错的工作,但存在多处语法的错误,需要对语言进行编辑修改,没让我补实验。收到修稿函后,花了半个月修稿完就提交了。提交后的第二天就从reviews completed 变为Accept 了。编辑挺负责的,总的来说还是挺快的…<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=832, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Sun Aug 02 10:34:35 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106157, encodeId=bf59210615e1d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:22年九月初投的稿,已经三个半月了还没外审回来,我真的无语了,看别人的都是一两个月就外审回来,再不外审回来真的生气了!!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Thu Dec 15 10:50:01 CST 2022, time=2022-12-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2106034, encodeId=15b42106034f6, content=编辑老师很认真负责,投稿接受修回都很快,让人感觉幸福来的很突然。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee172609672, createdName=yuanp25167257, createdTime=Wed Dec 14 17:00:18 CST 2022, time=2022-12-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223255, encodeId=d479122325552, content=这个杂志邮件通知手稿已经被接收了,但是接下来一周任何操作提示都没有,应该怎么办啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7965534931, createdName=lin112, createdTime=Sun May 29 23:06:38 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079947, encodeId=921810e994758, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床研究<br>经验分享:很不错的期刊,审稿速度,审稿效率都是很不错的。很欢迎上市后的临床研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/0A711D2CC5E0F3D07C1F1766E5448576/100, createdBy=6cd12546777, createdName=大鸟快跑, createdTime=Tue Dec 14 14:41:52 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092203, encodeId=b2c4109220373, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-12-14 yuanp25167257 来自江苏省

    编辑老师很认真负责,投稿接受修回都很快,让人感觉幸福来的很突然。

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2212854, encodeId=6cea221285452, content=偏重的研究方向:肿瘤;药物基础<br>经验分享:最近有没有投稿的小伙伴,这个杂志现在速度慢嘛,technical check一天多了都没动静,其他杂志check不就一小会么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Tue Jul 02 19:43:42 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178727, encodeId=79f721e872788, content=偏重的研究方向:肿瘤;药物<br>经验分享:reviewers invited 1 个月了没动静,找不到审稿人会退稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Tue Jan 02 09:44:27 CST 2024, time=2024-01-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2152225, encodeId=0ff52152225fc, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;药物<br>经验分享:23.5.1日投的稿<br>23.5.4 同行评审<br>23.6.12 返回意见<br>23.6.18 修回<br>23.6.21 接受<br>23.7.9 版权和APC问题<br>23.7.12 Pubmed 检索到<br><br>审稿人还是很友好专业的,个人觉得这个杂志1个月能找到审稿人还是很幸运的。接受后半个月没有任何动静,一旦给你发版权后,就很快了。可以选择没有版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ca5448733, createdName=ms1000000639469053, createdTime=Fri Aug 11 09:12:06 CST 2023, time=2023-08-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151942, encodeId=d07e215194211, content=请问案例报道可以投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=393e6422350, createdName=ms1000001764947106, createdTime=Wed Aug 09 14:05:45 CST 2023, time=2023-08-09, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=805722, encodeId=17a3805e22c1, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:六月十五投了篇,在编辑那停留了半个月后就under review,7月14日,外审结束,当晚就给了修稿,修稿意见是这样的:这是篇很不错的文章,总结一下很不错的工作,但存在多处语法的错误,需要对语言进行编辑修改,没让我补实验。收到修稿函后,花了半个月修稿完就提交了。提交后的第二天就从reviews completed 变为Accept 了。编辑挺负责的,总的来说还是挺快的…<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=832, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Sun Aug 02 10:34:35 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106157, encodeId=bf59210615e1d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:22年九月初投的稿,已经三个半月了还没外审回来,我真的无语了,看别人的都是一两个月就外审回来,再不外审回来真的生气了!!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Thu Dec 15 10:50:01 CST 2022, time=2022-12-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2106034, encodeId=15b42106034f6, content=编辑老师很认真负责,投稿接受修回都很快,让人感觉幸福来的很突然。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee172609672, createdName=yuanp25167257, createdTime=Wed Dec 14 17:00:18 CST 2022, time=2022-12-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223255, encodeId=d479122325552, content=这个杂志邮件通知手稿已经被接收了,但是接下来一周任何操作提示都没有,应该怎么办啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7965534931, createdName=lin112, createdTime=Sun May 29 23:06:38 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079947, encodeId=921810e994758, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床研究<br>经验分享:很不错的期刊,审稿速度,审稿效率都是很不错的。很欢迎上市后的临床研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/0A711D2CC5E0F3D07C1F1766E5448576/100, createdBy=6cd12546777, createdName=大鸟快跑, createdTime=Tue Dec 14 14:41:52 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092203, encodeId=b2c4109220373, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2022-05-29 lin112

    这个杂志邮件通知手稿已经被接收了,但是接下来一周任何操作提示都没有,应该怎么办啊?

    5

    展开5条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2212854, encodeId=6cea221285452, content=偏重的研究方向:肿瘤;药物基础<br>经验分享:最近有没有投稿的小伙伴,这个杂志现在速度慢嘛,technical check一天多了都没动静,其他杂志check不就一小会么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Tue Jul 02 19:43:42 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178727, encodeId=79f721e872788, content=偏重的研究方向:肿瘤;药物<br>经验分享:reviewers invited 1 个月了没动静,找不到审稿人会退稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Tue Jan 02 09:44:27 CST 2024, time=2024-01-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2152225, encodeId=0ff52152225fc, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;药物<br>经验分享:23.5.1日投的稿<br>23.5.4 同行评审<br>23.6.12 返回意见<br>23.6.18 修回<br>23.6.21 接受<br>23.7.9 版权和APC问题<br>23.7.12 Pubmed 检索到<br><br>审稿人还是很友好专业的,个人觉得这个杂志1个月能找到审稿人还是很幸运的。接受后半个月没有任何动静,一旦给你发版权后,就很快了。可以选择没有版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ca5448733, createdName=ms1000000639469053, createdTime=Fri Aug 11 09:12:06 CST 2023, time=2023-08-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151942, encodeId=d07e215194211, content=请问案例报道可以投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=393e6422350, createdName=ms1000001764947106, createdTime=Wed Aug 09 14:05:45 CST 2023, time=2023-08-09, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=805722, encodeId=17a3805e22c1, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:六月十五投了篇,在编辑那停留了半个月后就under review,7月14日,外审结束,当晚就给了修稿,修稿意见是这样的:这是篇很不错的文章,总结一下很不错的工作,但存在多处语法的错误,需要对语言进行编辑修改,没让我补实验。收到修稿函后,花了半个月修稿完就提交了。提交后的第二天就从reviews completed 变为Accept 了。编辑挺负责的,总的来说还是挺快的…<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=832, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Sun Aug 02 10:34:35 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106157, encodeId=bf59210615e1d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:22年九月初投的稿,已经三个半月了还没外审回来,我真的无语了,看别人的都是一两个月就外审回来,再不外审回来真的生气了!!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Thu Dec 15 10:50:01 CST 2022, time=2022-12-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2106034, encodeId=15b42106034f6, content=编辑老师很认真负责,投稿接受修回都很快,让人感觉幸福来的很突然。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee172609672, createdName=yuanp25167257, createdTime=Wed Dec 14 17:00:18 CST 2022, time=2022-12-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223255, encodeId=d479122325552, content=这个杂志邮件通知手稿已经被接收了,但是接下来一周任何操作提示都没有,应该怎么办啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7965534931, createdName=lin112, createdTime=Sun May 29 23:06:38 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079947, encodeId=921810e994758, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床研究<br>经验分享:很不错的期刊,审稿速度,审稿效率都是很不错的。很欢迎上市后的临床研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/0A711D2CC5E0F3D07C1F1766E5448576/100, createdBy=6cd12546777, createdName=大鸟快跑, createdTime=Tue Dec 14 14:41:52 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092203, encodeId=b2c4109220373, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-12-14 大鸟快跑

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤;临床研究
    经验分享:很不错的期刊,审稿速度,审稿效率都是很不错的。很欢迎上市后的临床研究。

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2212854, encodeId=6cea221285452, content=偏重的研究方向:肿瘤;药物基础<br>经验分享:最近有没有投稿的小伙伴,这个杂志现在速度慢嘛,technical check一天多了都没动静,其他杂志check不就一小会么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b1cc8157106, createdName=ms7000000138744330, createdTime=Tue Jul 02 19:43:42 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2178727, encodeId=79f721e872788, content=偏重的研究方向:肿瘤;药物<br>经验分享:reviewers invited 1 个月了没动静,找不到审稿人会退稿吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4ad59031879, createdName=ms4000001640011867, createdTime=Tue Jan 02 09:44:27 CST 2024, time=2024-01-02, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2152225, encodeId=0ff52152225fc, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;药物<br>经验分享:23.5.1日投的稿<br>23.5.4 同行评审<br>23.6.12 返回意见<br>23.6.18 修回<br>23.6.21 接受<br>23.7.9 版权和APC问题<br>23.7.12 Pubmed 检索到<br><br>审稿人还是很友好专业的,个人觉得这个杂志1个月能找到审稿人还是很幸运的。接受后半个月没有任何动静,一旦给你发版权后,就很快了。可以选择没有版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e7ca5448733, createdName=ms1000000639469053, createdTime=Fri Aug 11 09:12:06 CST 2023, time=2023-08-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2151942, encodeId=d07e215194211, content=请问案例报道可以投吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=393e6422350, createdName=ms1000001764947106, createdTime=Wed Aug 09 14:05:45 CST 2023, time=2023-08-09, status=1, ipAttribution=内蒙古), GetPortalCommentsPageByObjectIdResponse(id=805722, encodeId=17a3805e22c1, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享:六月十五投了篇,在编辑那停留了半个月后就under review,7月14日,外审结束,当晚就给了修稿,修稿意见是这样的:这是篇很不错的文章,总结一下很不错的工作,但存在多处语法的错误,需要对语言进行编辑修改,没让我补实验。收到修稿函后,花了半个月修稿完就提交了。提交后的第二天就从reviews completed 变为Accept 了。编辑挺负责的,总的来说还是挺快的…<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=832, replyNumber=9, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68e94695506, createdName=1424056585, createdTime=Sun Aug 02 10:34:35 CST 2020, time=2020-08-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2106157, encodeId=bf59210615e1d, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤<br>经验分享:22年九月初投的稿,已经三个半月了还没外审回来,我真的无语了,看别人的都是一两个月就外审回来,再不外审回来真的生气了!!!!!!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d555680512, createdName=ms5000002035322087, createdTime=Thu Dec 15 10:50:01 CST 2022, time=2022-12-15, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2106034, encodeId=15b42106034f6, content=编辑老师很认真负责,投稿接受修回都很快,让人感觉幸福来的很突然。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee172609672, createdName=yuanp25167257, createdTime=Wed Dec 14 17:00:18 CST 2022, time=2022-12-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223255, encodeId=d479122325552, content=这个杂志邮件通知手稿已经被接收了,但是接下来一周任何操作提示都没有,应该怎么办啊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7965534931, createdName=lin112, createdTime=Sun May 29 23:06:38 CST 2022, time=2022-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079947, encodeId=921810e994758, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤;临床研究<br>经验分享:很不错的期刊,审稿速度,审稿效率都是很不错的。很欢迎上市后的临床研究。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=82, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/0A711D2CC5E0F3D07C1F1766E5448576/100, createdBy=6cd12546777, createdName=大鸟快跑, createdTime=Tue Dec 14 14:41:52 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092203, encodeId=b2c4109220373, content=我是写那种格式的摘要比较好?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=)]
    2021-12-29 Mia

    我是写那种格式的摘要比较好?

    1

    展开1条回复
共39条页码: 1/4页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map